The state of reproductive organs of young and aged male rats with the prolonged administration of letrozole and after its withdrawal

Authors

  • О. H. Reznikov V.P. Komisarenko Institute of Endocrinology and Metabolism, NAMS of Ukraine, Kyiv,
  • O.V. Sachynska V.P. Komisarenko Institute of Endocrinology and Metabolism, NAMS of Ukraine, Kyiv,
  • L.I. Poliakova V.P. Komisarenko Institute of Endocrinology and Metabolism, NAMS of Ukraine, Kyiv,
  • O. A. Faliush V.P. Komisarenko Institute of Endocrinology and Metabolism, NAMS of Ukraine, Kyiv,
  • O.V. Yanishevskyi V.P. Komisarenko Institute of Endocrinology and Metabolism, NAMS of Ukraine, Kyiv,

DOI:

https://doi.org/10.14739/2310-1237.2018.3.151647

Keywords:

letrozole, male reproductive system, rats

Abstract

Aim. Study of the reproductive organs after long-term administration of letrozole, the steroid aromatase inhibitor, followed by its withdrawal in young male rats and ones with age-related involution of reproductive organs.

Material and methods. The experiments were carried out on Wistar rats with an initial age of 5 months and 15 months, which were gavaged with letrozole every other day at a dose of 1 mg/kg bw for 3 months and then 2 months following its discontinuation. The blood plasma testosterone and estradiol levels were measured by immunoassays. The spermatozoa contents in epididymis were calculated. The testicles and accessory sexual glands were weighed, and morphology of gonads and ventral prostate was studied. The results of the study were compared with those of control animals of corresponding age.

Results. As the result of letrozole treatment, the ratio of testosterone and estradiol levels in blood plasma of aged rats increased. The spermatozoa content in epididymis rose up by on the average 28 %. The histological study revealed functional activation of Leydig cells, a significant retardation of involutive changes of their number and morphology. Some Leydig cells demonstrated the signs of functional exhaustion. Letrozole exerted an increase of relative weight of the coagulation gland by an average of 40 %, seminal vesicles by 31 %, and ventral prostate by 33 % compared with those of control animals. Two months after letrozole withdrawal, there were no signs of difference between letrozole-treated and control animals. In young rats, the effects of letrozole were almost not detectable.

Conclusions. Letrozole administration to male rats with age-related involution of the reproductive system increases testosterone/estradiol ratio in blood plasma, the spermatozoa contents in epididymises and the weights of androgen-dependent accessory sexual glands. This is accompanied by slowing down of age-related changes of the gonad morphology and prostate gland. Letrozole-induced reproductive effects are reversible.


References

Rastrelli, G., Maggi, M., & Corona, G. (2018). Pharmacological management of late-onset hypogonadism. Expert Rev Clin Pharmacol., 11(4), 439–458. doi: 10.1080/17512433.2018.1445969.

Luchytskyy, Ye. V., & Luchytskyy, V. Ye. (2012). Suchasnі pohliady na vіkovyi androhenodefіtsyt u cholovіkіv [Modern concept of age androgendefiсiensy in males]. Endokrynolohia, 4, 56–60. [in Ukrainian].

Reznikov, A. G. (2014). Vzglyad patofiziologa-e'ndokrinologa na problemu vozrastnogo deficita androgenov u muzhchin (LOH-sindrom) [The point of view of pathophysiologistendocrinologist on the problem of age-related androgen deficiency in men (LOH-syndrome)]. Mizhnarodnyi endokrynolohichnyi zhurnal, 6(62), 11–18. [in Russian].

Ahmed, K., Hatzimouratidis, K., & Muneer, A. (2017). Male Sexual Dysfunction and Hypogonadism Guidelines for the Aging Male. Eur Urol Focus, 3(4-5), 514–516. doi: 10.1016/j.euf.2017.12.004.

Decaroli, M. C., & Rochira, V. (2017). Aging and sex hormones in males. Virulence, 8(5), 545–570. doi: [10.1080/21505594.2016.1259053].

Blaya, R., Blaya, P., Rhoden, L., & Rhoden, E. L. (2017). Low Testosterone Levels and Metabolic Syndrome in Aging Male. Curr Pharm Des, 23(30), 4470–4474. doi: 10.2174/1381612823666170503150955.

Pye, S. R., Huhtaniemi, I. T., Finn, J. D., Lee, D. M., O'Neill, T. W., Tajar, A., et al. (2014). Late-onset hypogonadism and mortality in aging men. J. Clin. Endocrinol. Metab., 99(4), 1357–1366. doi: 10.1210/jc.2013-2052.

Rhoden, E. L., & Morgentaler, A. (2004). Risks of testosterone-replacement therapy and recommendations for monitoring. New England J. Med., 350(5), 482–492. doi: 10.1056/NEJMra022251.

Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., &. Montori, V. M. (2006). Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab., 91(6), 1995–2010. https://doi.org/10.1210/jc.2005-2847.

Solov´ev, A. I., Reznikov, A. G., Tarasenko, L. V., & Margitich, V. M. (2006). Pervyj v Ukraine uspeshnyj opyt primeneniya biovejvera dlya e´kspertnoj ocenki lekarstvennogo sredstva (Letromara) [The first successful biowaiver application in Ukraine for the expert evaluation of a medicinal product (Letromara)]. Zhurnal AMN Ukrainy, 12(4), 781–793. [in Russian].

Tarasenko, L. V., & Reznikov, O. G. (2007). Patohenetychna rol ovarіalnoi aromatazy steroidіv u rozladakh statevoi tsyklichnostі [Pathogenetic role of ovarian steroid aromatase in disorders of sexual cycle]. Fiziolohichnyi zhurnal, 53(1), 11–15. [in Ukrainian].

Bhatnagar, A. S., Muller, P., Schenkel, L., Trunet, P. F., Beh, I., & Schieweck, K. (1992). Inhibition of estrogen biosynthesis and its consequences on gonadotrophin secretion in the male. J Steroid Biochem Mol Biol, 41(3–8), 437–443. https://doi.org/10.1016/0960-0760(92)90369-T.

De Boer, H., Verschoor, L., Ruinemans-Koerts, J., & Jansen, M. (2005). Letrozole normalizes serum testosterone in severely obese men with hypogonadotropic hypogonadism. Diabetes, Obesity and Metabolism, 7(3), 211–215. doi: 10.1111/j.1463-1326.2004.00397.x

Loves, S., Ruinemans-Koerts, J., De Boer, H. (2008). Letrozole once a week normalizes serum testosterone in obesity-related male hypogonadism. European J. Endocrinol., 158(5), 741–7. doi: 10.1530/EJE-07-0663.

De Ronde, W., & De Jong, F. H. (2011). Aromatase inhibitors in men: effects and therapeutic options. Reprod Biol Endocrinol., 9, 93. doi: 10.1186/1477-7827-9-93.

Zhao, D., Pan, L., Zhang, F., Pan, F., Ma, J., Zhang, X., & Liu, Y. (2014). Successful use of aromatase inhibitor letrozole in NOA with an elevated FSH level: a case report. Andrologia, 46(4), 456–457. doi: 10.1111/and.12122.

Ribeiro, M. A., Gameiro, L. F., Scarano, W. R., Briton-Jones, C., Kapoor, A., Rosa, M. B., & El Dib, R. (2016). Aromatase inhibitors in the treatment of oligozoospermic or azoospermic men: a systematic review of randomized controlled trials. JBRA Assist Reprod., 20(2), 82–88. doi: 10.5935/1518-0557.20160019.

Bibancos, M., Cavagnoli, M., Bonetti, T. C., Semaco, E., Motta, E. L., & Serafini, P. C. (2015). Letrozole Therapy for Obstructive Azoospermic Men before in vitro Fertilization (IVF) treatment with Percutaneous Epididymal Sperm Aspiration. JBRA Assist Reprod., 19(4), 230–234. doi: 10.5935/1518-0557.20150045.

Gregoriou, O., Bakas, P., Grigoriadis, C., Creatsa, M., Hassiakos, D., & Creatsas, G. (2012). Changes in hormonal profile and seminal parameters with use of aromatase inhibitors in management of infertile men with low testosterone to estradiol ratios. Fertil Steril, 98(1), 48–51. doi: 10.1016/j.fertnstert.2012.04.005.

Leder, B. Z., Rohrer, J. L., Rubin, S. D., Gallo, J., & Longcope, C. (2004). Effects of aromatase inhibition in elderly men with low or borderline-low serum testosterone levels. J Clin Endocrinol Metab, 89(3), 1174–1180. doi: 10.1210/jc.2003-031467.

Burnett-Bowie, S. A., Roupenian, K. C., Dere, M. E., Lee, H., & Leder, B. Z. (2009). Effects of aromatase inhibition in hypogonadal older men: a randomized, double-blind, placebo-controlled trial. Clinical Endocrinology, 70(1), 116–123. doi: 10.1111/j.1365-2265.2008.03327.x.

Schlegel, P. N. (2012). Aromatase inhibitors for male infertility. Fertil Steril, 98(6), 13559–13562. doi: 10.1016/j.fertnstert.2012.10.023.

Tan, R. B., Guay, A. T., & Hellstrom, W. J. (2014). Clinical Use of Aromatase Inhibitors in Adult Males. Sex Med Rev, 2(2), 79–90. doi: 10.1002/smrj.23.

Haynes, B. P., Dowsett, M., Miller, W. R., Dixon, J. M., & Bhatnagar A. S. (2003). The pharmacology of letrozole. J Steroid Biochem Mol Biol, 87(1), 35-45.

Pouliot, L., Schneider, M., DeCristofaro, M., Samadfam, R., Smith, S. Y., & Beckman, D. A. (2013). Assessment of a nonsteroidal aromatase inhibitor, letrozole, in juvenile rats. Birth Defects Res B Dev Reprod Toxicol, 98(5), 374–390. doi: 10.1002/bdrb.21080.

Selim, M. E., Aleisa, N. A., & Daghestani, M. H. (2013). Evaluation of the possible protective role of quercetin on letrozole-induced testicular injury in male albino rats. Ultrastruct Pathol, 37(3), 204–217. doi: 10.3109/01913123.2013.772269.

Reznikov, O. G., Chaikovska, L. V., Polyakova, L. I., Sachynska, O. V., Yanishevsky, O. V. (2015). Vіkovі osoblyvostі reaktsіi reproduktyvnoi systemy samtsіv shhurіv na letrozol [Age-related peculiarities of the response of male rat reproductive system to letrozole]. Endokrynolohia, 20(1), 425–430. [in Ukrainian].

Zapadnyuk, I. P., Zapadnyuk, V. I., & Zakhariya, E. A. (1974) Laboratornye zhyvotnye [Laboratory animals]. Kyiv. [in Russian].

Gelashvily, O. A. (2008). Variant periodizacii biologicheski skhodnykh stadij ontogeneza cheloveka i krysy [Variant of periodization of biologically similar stages of human and rat’s ontogenesis]. Saratovskij nauchno-medicinskij zhurnal, 4(22), 125–126. [in Russian].

Turner, K. J., Morley, M., Atanassova, N., Swanston, I. D., Sharpe, R. M. (2000). Effect of chronic administration of an aromatase inhibitor to adult male rats on pituitary and testicular function and fertility. J Endocrinol., 162(2), 225–238.

Vanderschueren, D., Boonen, S., Ederveen, A. G., de Coster, R., Van Herck, E., Moermans, K., et al. (2000). Skeletal effects of estrogen deficiency as induced by an aromatase inhibitor in an aged male rat model. Bone, 27(5), 611–617.

Downloads

How to Cite

1.
Reznikov ОH, Sachynska O, Poliakova L, Faliush OA, Yanishevskyi O. The state of reproductive organs of young and aged male rats with the prolonged administration of letrozole and after its withdrawal. Pathologia [Internet]. 2018Dec.19 [cited 2024Apr.25];(3). Available from: http://pat.zsmu.edu.ua/article/view/151647

Issue

No. 3 (2018)

Section

Original research

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Лицензия Creative Commons
    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

  1. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).